Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 196.17M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -4.54M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 31.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 33.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -13.00% |
| Recommedations | - | Quick Ratio | 0.17 | Shares Outstanding | 11.93M | 52W Low Chg | 100.00% |
| Insider Own | 0.75% | ROA | -2.46% | Shares Float | 9.45M | Beta | - |
| Inst Own | 95.82% | ROE | - | Shares Shorted/Prior | 401.03K/500.87K | Price | 13.25 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 92,829 | Target Price | - |
| Oper. Margin | - | Earnings Date | Mar 31 | Volume | 554,068 | Change | 19.80% |
About Helix Acquisition Corp.
As of April 5, 2022, Helix Acquisition Corp. was acquired by MoonLake Immunotherapeutics AG, in a reverse merger transaction. Helix Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was founded in 2020 and is based in Boston, Massachusetts.